In an interview with The Telegraph, Genevieve Edwards, from the MS Society, said:
“This is very encouraging progress for thousands of people with MS who have been forced to choose between living with relentless pain and muscle spasm or breaking the law.”
One of the main developments is the news that patients will no longer need to suffer on traditional, pharmaceutical medications before being recommended for medical cannabis treatments.
Previously, patients had to endure the ordeal of taking pharmaceutical, normally opioid-based, medications, which can be addictive and lead to further symptoms; often leading patients to being prescribed even more medications to deal with the side-effects of the initial prescription.
Discussing the developments, a spokesperson for the Government said:
“We completely sympathise with the families who have been facing desperate situations as they try to find treatment.”
“In July the Home Secretary committed to swift action on behalf of those whose medical conditions could potentially be eased by cannabis-based products and we have announced that cannabis-based products for medicinal use will be available for specialist doctors to prescribe legally from the Autumn.
“In the interim the expert panel will consider applications for these products. Any proposed course of treatment with cannabis-based medicine must be clinically led.’